Recent News
March 1, 2026 and April 1, 2026 delivery updates showed recovery in retail demand: January deliveries reported roughly 27,668 units, February deliveries about 26,421 units, and March deliveries rose to 41,053 units, indicating sequential acceleration; separate coverage noted a production ramp of the i6 model amid prior supply constraints. These updates came alongside routine corporate releases on retail and service network expansion in China.
Technical Analysis
ADX/DI+/DI-: ADX at 14.48 signals no established trend, but DI+ at 36.05 increasing and DI- at 25.37 decreasing indicate directional strength favoring buyers; that combination implies short-term directional pressure that may support further price gains, even while the broader trend lacks strength.
MACD: MACD sits at 0.23 with the signal line at 0.11 and an increasing MACD_trend; MACD recently crossed above its signal line, a bullish momentum confirmation that supports the near-term upside suggested by the directional indicators.
MRO: MRO reads -17.03 (negative), which means price sits below the modeled target and thus presents upward potential; the negative MRO aligns with the expectation of mean-reversion that could fuel further short-term gains.
RSI: RSI 52.15 and increasing shows mild bullish momentum without overbought conditions, supporting a continuation of the recent rally rather than signaling exhaustion.
Price Structure & Moving Averages: Close at $19.21 sits above the 20-day average ($18.09), the 50-day average ($17.90) and the 12-day EMA ($18.29) — all rising — while remaining below the 200-day average ($21.16). Price trades near the upper Bollinger band (upper 1σ $18.72, upper 2σ $19.35), suggesting momentum with limited short-term volatility. Ichimoku components (Senkou A $17.94, Senkou B $17.52) and the super trend lower support ($17.91) lie below price, providing short-term structural support for swing traders.
Fundamental Analysis
Earnings & Per-Share Metrics: Latest reported EPS actual $0.01 versus estimate -$0.02, an EPS beat of $0.03, representing a 150% surprise to the estimate. Forward EPS stands at $0.22 with a forward P/E of 82.18. Current reported P/E equals $1,802.89, well above the industry peer mean of 85.88 and above the industry peer high of 172.68, reflecting extreme valuation relative to peers.
Growth Rates: Reported earnings growth shows -101.61% (earningsGrowth), with quarter-over-quarter earnings down ~36.57% and year-over-year earnings change of -515.83% as reported; revenue growth registers 0% overall with quarter-over-quarter and year-over-year revenue reductions shown as -100% in the provided metrics. Those declines highlight recent compression in core operating momentum relative to prior periods.
Profitability & Cash: Cash flow margin: 0.0% and cash flow to earnings: 0.0% per the data. Invested capital reads negative $80,786,194,000. Cost of debt registers 0.159%, indicating very low borrowing costs on reported debt. Free-cash-flow non-GAAP figures included in the company release show a swing from prior negative to positive in the most recent annual figures, consistent with delivery stabilization reports.
Valuation Multiples & Peer Comparisons: PEG ratio reported at -17.74, below the industry peer low of -2.92 and well beneath the industry peer mean of -1.70 and median of -1.45; forward PEG sits at -0.81. The forward P/E of 82.18 sits below the current trailing P/E but remains elevated versus the industry peer mean (forward peer mean 39.40, median 24.60). WMDST values the stock as over-valued given stretched trailing multiples against constrained growth metrics.
Earnings Calendar: Most recent report dated March 12, 2026; next scheduled report listed for June 11, 2026. The latest operational releases emphasize delivery recovery and production ramping rather than material margin improvement to date.
Valuation Note: The current valuation as determined by WMDST classifies the stock as over-valued, reflecting a combination of inflated multiples, compressed reported growth, and a modest recovery in deliveries that has not yet reconciled with trailing valuation.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-03-12 |
| NEXT REPORT DATE: | 2026-06-11 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ -0.02 | |
| EPS Actual | $ 0.01 | |
| EPS Difference | $ 0.03 | |
| EPS Surprise | 150.0 % | |
| Forward EPS | $ 0.22 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 1802.891 | |
| Price To Earnings QoQ | -5182.009 % | |
| Price To Earnings YoY | 22919.313 % | |
| Price To Earnings IPRWA | LI: 1802.891 high: 172.68 mean: 85.881 median: 47.288 low: -128.535 |
|
| PE/G Ratio | -17.743 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 82.179 | |
| Forward PE/G | -0.809 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 278.075 mean: 26.075 median: 13.988 low: 13.061 LI: 0 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -80.79 B | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 0.159 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | high: 55.306 % LI: 0.0 % mean: -9.763 % median: -11.369 % low: -17.458 % |
|
| Earnings Growth | -101.613 % | |
| Earnings Growth QoQ | -36.569 % | |
| Earnings Growth YoY | -515.833 % | |
| Earnings Growth IPRWA | high: 16.226 % mean: -50.794 % median: -71.111 % LI: -101.613 % low: -178.71 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | 0.0 % | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |